1. Home
  2. BMRN vs UHAL Comparison

BMRN vs UHAL Comparison

Compare BMRN & UHAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRN
  • UHAL
  • Stock Information
  • Founded
  • BMRN 1996
  • UHAL 1945
  • Country
  • BMRN United States
  • UHAL United States
  • Employees
  • BMRN N/A
  • UHAL N/A
  • Industry
  • BMRN Biotechnology: Pharmaceutical Preparations
  • UHAL Rental/Leasing Companies
  • Sector
  • BMRN Health Care
  • UHAL Consumer Discretionary
  • Exchange
  • BMRN Nasdaq
  • UHAL Nasdaq
  • Market Cap
  • BMRN 9.9B
  • UHAL 11.2B
  • IPO Year
  • BMRN 1999
  • UHAL N/A
  • Fundamental
  • Price
  • BMRN $54.90
  • UHAL $51.42
  • Analyst Decision
  • BMRN Buy
  • UHAL
  • Analyst Count
  • BMRN 19
  • UHAL 0
  • Target Price
  • BMRN $90.26
  • UHAL N/A
  • AVG Volume (30 Days)
  • BMRN 2.8M
  • UHAL 128.0K
  • Earning Date
  • BMRN 10-27-2025
  • UHAL 11-05-2025
  • Dividend Yield
  • BMRN N/A
  • UHAL N/A
  • EPS Growth
  • BMRN 59.53
  • UHAL N/A
  • EPS
  • BMRN 2.68
  • UHAL 1.19
  • Revenue
  • BMRN $3,094,001,000.00
  • UHAL $5,972,459,000.00
  • Revenue This Year
  • BMRN $13.32
  • UHAL $3.18
  • Revenue Next Year
  • BMRN $7.51
  • UHAL $3.71
  • P/E Ratio
  • BMRN $20.42
  • UHAL $43.12
  • Revenue Growth
  • BMRN 12.39
  • UHAL 5.86
  • 52 Week Low
  • BMRN $50.76
  • UHAL $50.49
  • 52 Week High
  • BMRN $73.51
  • UHAL $75.19
  • Technical
  • Relative Strength Index (RSI)
  • BMRN 55.73
  • UHAL 30.48
  • Support Level
  • BMRN $50.76
  • UHAL $51.99
  • Resistance Level
  • BMRN $55.34
  • UHAL $53.14
  • Average True Range (ATR)
  • BMRN 1.76
  • UHAL 1.26
  • MACD
  • BMRN 0.33
  • UHAL -0.14
  • Stochastic Oscillator
  • BMRN 67.96
  • UHAL 19.65

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About UHAL U-Haul Holding Company

U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.

Share on Social Networks: